Clinical Trial Update: Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating dexamethasone, azacytidine, pegaspargase, and tislelizumab for NK/T cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pegaspargase (pegaspargase)
• Tislelizumab (tislelizumab)
• azacytidine (azacitidine)

Snippet

Sponsor: Peking University | Conditions: NK/T Cell Lymphoma | Phase 2 | Status: UNKNOWN